Airlook, a Chinese three-dimensional map provider, has raised nearly RMB100 million ($14 million) in an extended Series B round led by GF Qianhe, the alternative investment arm of Hong Kong-listed GF Securities.
Existing investors Ivy Capital, GGV Capital and Baidu Ventures have re-upped. GGV Capital led the company’s RMB50 million Series B in 2018. Founded in 2015, Airlook specializes in aeronautical data...
Increased climate change awareness on a corporate level is leading to more investment – either direct or through funds – in start-ups that offer mitigation solutions. Asia is a key geography
Healthcare-focused Panacea Venture has led a $40 million Series C round for China’s XWPharma, a neurobiology-focused biotech developer previously known as XW Laboratories.
Kyee Technology, a Chinese digital medical platform has raised RMB430 million ($64 million) in a Series D round led by Tencent Holdings. Other investors include Longmen Capital, Dyee Capital and Royal Sea Capital.
Biocytogen, a Chinese contract research organization (CRO) that provides genetically-modified mice for drug testing, has raised RMB970 million ($143 million) in an extended tranche of Series D funding.